I am an Assistant Professor in Molecular and Genetic Cancer Epidemiology at the Department of Biosciences and Nutrition.
My main scientific interest is in the search of understanding the specific patient and tumor characteristics required throughout tumor progression to enable the cancer tumor to gain early or late metastatic capacity, in the end responsible for virtually all cancer-related death.
I focus my research around breast cancer that is the most common female cancer in the Western world. One in four women diagnosed with breast cancer will later develop distant metastatic disease and die. Breast cancer is widely recognized as a heterogeneous disease in the sense of both primary tumor metastatic capacity as well as time to metastatic spread of disease.
- MSc (Master of Science) in Molecular Biotechnology, Uppsala University.
- PhD in Cancer Epidemiology, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet.
Main research questions:
- Does intra-tumor heterogeneity influence cancer patient survival and response to therapy?
- Breast cancer in situ: Who is at high risk to develop invasive breast cancer?
- Molecular definition of an “indolent” tumor? Identify patients at very low risk for fatal breast cancer.
- Why do young women with breast cancer have poor prognosis?
- Is breast cancer survival inherited?
Academic honors, awards and prizes
- 3-year full Postdoctoral Research position from the Swedish Research Council (Vetenskapsrådet).
- 4-year Young Investigator “Unga Forskare” Project Research Grant from the Swedish Research Council (Vetenskapsrådet).
- 4-year Young Investigator Award from the Swedish Research Council for Health, Working life and Welfare (FORTE).